Trailing-twelve-month (TTM) revenue is $4.60 Billion with a year-over-year growth of +14.20%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q4 FY2025Period ended 2025-09-27 | $1,058,366,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-14 |
| Q1 FY2026Period ended 2026-01-03 | $1,069,852,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-05 |
| Q2 FY2026Period ended 2026-04-04 | $1,163,757,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-07 |
| Q3 FY2026Period ended 2026-07-04 | $1,304,778,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-06 |
| TTM revenue | $4,596,753,000 |
Current P/S: $6,601,611,753 market capitalization ÷ $4,596,753,000 TTM revenue = 1.44x.
Market capitalization source: FMP quote. Quote observed 2026-09-18T20:00:00.000Z. Latest revenue period ended 2026-07-04.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q3 FY2026 (2026-07-04): $1.30B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-19T00:15:54.237Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-09-27 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-09-27 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-10-03 · USD | FY20212021-10-02 · USD | FY20222022-10-01 · USD | FY20232023-09-30 · USD | FY20242024-09-28 · USD | FY20252025-09-27 · USD |
|---|---|---|---|---|---|---|
| Americas Segment | $1.3B | $1.3B | $1.3B | $1.6B | $1.3B | $1.2B |
| Asia Pacific Segment | $1.8B | $1.9B | $2.3B |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-10-03 · USD | FY20212021-10-02 · USD | FY20222022-10-01 · USD | FY20232023-09-30 · USD | FY20242024-09-28 · USD | FY20252025-09-27 · USD |
|---|---|---|---|---|---|---|
| Americas | $1.3B | N/A | N/A | N/A | N/A | N/A |
| Americas Segment | N/A | $1.3B |
$4.60B
$4.60 Billion
+14.20%
vs. $4.03B a year ago (TTM)
+5.97%
5 Year compound annual growth rate
1 Year
+14.20%
3 Year
+2.16%
5 Year
+5.97%
10 Year
+5.98%
15 Year
+4.88%
20 Year
+6.18%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $4.03B | +$72.14M | +1.82% |
| 2024 | $3.96B | ($249.48M) | (5.93%) |
| 2023 | $4.21B | +$398.94M | +10.47% |
| 2022 | $3.81B | +$442.50M | +13.14% |
| 2021 | $3.37B | ($21.53M) | (0.63%) |
| 2020 |
TTM Growth
+14.20%
3-Year CAGR
+2.16%
5-Year CAGR
+5.97%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-19T00:15:54.237Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $2.2B |
| $2.4B |
| EMEA Segment | $349M | $313M | $316M | $403M | $542M | $440M |
|---|
| $1.6B |
| $1.3B |
| $1.2B |
| Asia Pacific | $1.8B | N/A | N/A | N/A | N/A | N/A |
|---|
| Asia Pacific Segment | N/A | $1.9B | $2.3B | $2.4B | $2.2B | $2.4B |
|---|
| EMEA | $349M | N/A | N/A | N/A | N/A | N/A |
|---|
| EMEA Segment | N/A | $313M | $316M | $403M | $542M | $440M |
|---|
| $3.39B |
| +$225.96M |
| +7.14% |
| 2019 | $3.16B | +$290.93M | +10.12% |
| 2018 | $2.87B | +$345.46M | +13.66% |
| 2017 | $2.53B | ($27.95M) | (1.09%) |
| 2016 | $2.56B | ($98.29M) | (3.70%) |
